Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
FSD Pharma Inc is a drug manufacturers-specialty & generic business based in the US. FSD Pharma shares (HUGE) are listed on the NASDAQ and all prices are listed in US Dollars. FSD Pharma employs 9 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $0.87 |
|---|---|
| 52-week range | $0.83 - $4.44 |
| 50-day moving average | $1.18 |
| 200-day moving average | $1.54 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.13 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.8749 from 2022-01-27
| 1 week (2022-01-20) | -14.23% |
|---|---|
| 1 month (2021-12-24) | N/A |
| 3 months (2021-10-28) | -37.06% |
| 6 months (2021-07-28) | -48.84% |
| 1 year (2021-01-28) | -57.94% |
|---|---|
| 2 years (2020-01-28) | -86.27% |
| 3 years (2019-01-28) | 272.30% |
| 5 years (2017-01-24) | N/A |
Valuing FSD Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of FSD Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
FSD Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $428,232.
The EBITDA is a measure of a FSD Pharma's overall financial performance and is widely used to measure a its profitability.
| Gross profit TTM | $-3,331,945 |
|---|---|
| Return on assets TTM | -37.87% |
| Return on equity TTM | -68.93% |
| Profit margin | 0% |
| Book value | $1.49 |
| Market capitalisation | $37.4 million |
TTM: trailing 12 months
We're not expecting FSD Pharma to pay a dividend over the next 12 months.
FSD Pharma's shares were split on a 1:201 basis on 15 October 2019. So if you had owned 201 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FSD Pharma shares – just the quantity. However, indirectly, the new 20000% higher share price could have impacted the market appetite for FSD Pharma shares which in turn could have impacted FSD Pharma's share price.
Over the last 12 months, FSD Pharma's shares have ranged in value from as little as $0.8251 up to $4.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FSD Pharma's is 1.0303. This would suggest that FSD Pharma's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
FSD Pharma Inc. , through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA. ; and with Innovet Italia S. R.
Lido’s liquid staking allows investors holding LUNA and less than 32 ETH to reap the rewards of DeFi staking.
Downturns often let you buy fundamentally strong stocks at bargain prices, but mind the fundamentals and consider these 3 rules.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.